ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4427
+0.0147 (3.43%)
At close: Sep 26, 2025, 4:00 PM EDT
0.4331
-0.0096 (-2.17%)
After-hours: Sep 26, 2025, 7:59 PM EDT
ProPhase Labs Employees
ProPhase Labs had 96 employees as of December 31, 2024. The number of employees decreased by 17 or -15.04% compared to the previous year.
Employees
96
Change (1Y)
-17
Growth (1Y)
-15.04%
Revenue / Employee
$58,208
Profits / Employee
-$431,792
Market Cap
18.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PRPH News
- 4 days ago - PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE - GlobeNewsWire
- 5 days ago - ProPhase Continues its Exploration of a Crypto Treasury Strategy - GlobeNewsWire
- 15 days ago - ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor - GlobeNewsWire
- 24 days ago - ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 - GlobeNewsWire
- 5 weeks ago - ProPhase Labs, Inc. (PRPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders - GlobeNewsWire
- 6 weeks ago - ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewsWire
- 6 weeks ago - ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment - GlobeNewsWire